Celagenex Research (India) PVT. Ltd.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Dec 2039
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Sep 12, 2027The maintenance fee for Synergistic Nutritional Compositions for Treating Cerebrovascular Diseases (US 11,925,195) comes due Sep 12, 2027. Unpaid by Mar 13, 2028, it lapses early.
- 1 fee due Nov 19, 2027The maintenance fee for Synergistic nutritional compositions for pain management (US 10,653,737) comes due Nov 19, 2027. Unpaid by May 19, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,013,710 | Synergistic compositions of bioactive agents for optimizing cellular health In force · USPTO record | In force | USPTO record | |
| US 10,653,737 | Synergistic nutritional compositions for pain management In force · USPTO record | In force | USPTO record | |
| US 10,864,207 | Method of treating endothelial dysfunction In force · USPTO record | In force | USPTO record | |
| US 11,491,175 | Synergistic bioactive compositions for enhancing cellular energy In force · USPTO record | In force | USPTO record | |
| US 12,036,193 | Synergistic bioactive compositions for treating neurological disorders In force · USPTO record | In force | USPTO record | |
| US 11,285,167 | Synergistic nutritional neuroprotective compositions for ameliorating neural dysfunction In force · USPTO record | In force | USPTO record | |
| US 11,925,195 | Synergistic Nutritional Compositions for Treating Cerebrovascular Diseases In force · High confidence | In force | High confidence | |
| US 11,166,941 | Synergistic nutritional compositions for enhancing ATP efficiency In force · USPTO record | In force | USPTO record | |
| US 11,229,626 | Synergistic nutritional compositions for treating seizures and chronic inflammatory diseases In force · USPTO record | In force | USPTO record | |
| US 11,376,277 | Synergistic medicinal compositions for treating dysfunctional D-serine signaling In force · USPTO record | In force | USPTO record |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending